Selenium and risk of bladder cancer: A population-based case-control study

Cancer Prevention Research

Volumn 2, Issue 1, 2009, Pages 70-73

  Wallace, Kristin ^a   Kelsey, Karl T ^c   Schned, Alan ^a   Morris, J Steven ^b   Andrew, Angeline S ^a   Karagas, Margaret R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; SELENIUM;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLADDER CANCER; CANCER INCIDENCE; CANCER PREVENTION; CANCER REGISTRY; CANCER RISK; CANCER TISSUE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NAIL; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING HABIT; TISSUE LEVEL; BLADDER TUMOR; CASE CONTROL STUDY; CHEMISTRY; METABOLISM; MIDDLE AGED; RISK FACTOR; SMOKING;

CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NAILS; RISK FACTORS; SELENIUM; SEX FACTORS; SMOKING; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 62349115017     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-08-0046     Document Type: Article

References (22)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Zeegers MP, Kellen E, Buntinx F, van den Brandt PA. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol 2004;21:392-401.
3. Brinkman M, Buntinx F, Muls E, Zeegers MP. Use of selenium in chemoprevention of bladder cancer. Lancet Oncol 2006;7:766-774 (Pubitemid 44283670)
4. Rayman MP. Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc 2005;64:527-542 (Pubitemid 41705454)
5. Michaud DS, De Vivo I, Morris JS, Giovannucci E. Toenail selenium concentrations and bladder cancer risk in women and men. Br J Cancer 2005;93:804-806 (Pubitemid 41486441)
6. Kellen E, Zeegers M, Buntinx F. Selenium is inversely associated with bladder cancer risk: a report from the Belgian case-control study on bladder cancer. Int J Urol 2006;13:1180-1184 (Pubitemid 44410906)
7. Zeegers MP, Goldbohm RA, Bode P, van den Brandt PA. Prediagnostic toenail selenium and risk of bladder cancer. Cancer Epidemiol Biomarkers Prev 2002;11:1292-1297 (Pubitemid 35340363)
8. Yalcin O, Karatas F, Erulas FA, Ozdemir E. The levels of glutathione peroxidase, vitamin A, E, C and lipid peroxidation in patients with transitional cell carcinoma of the bladder. BJU Int 2004;93:863-866
9. Michaud DS, Hartman TJ, Taylor PR, et al. No association between toenail selenium levels and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1505-1506 (Pubitemid 35340395)
10. Smith ML, Lancia JK, Mercer TI, Ip C. Selenium compounds regulate p53 by common and distinctive mechanisms. Anticancer Res 2004;24:1401-1408 (Pubitemid 38954655)
11. Luis NM, Lopez-Knowles E, Real FX. Molecular biology of bladder cancer. Clin Transi Oncol 2007;9:5-12.
12. Karagas MR, Tosteson TD, Morris JS, et al. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control 2004;15:465-472
13. Mom's J, Stampfer M, Willett W. Dietary selenium in humans, toenails as an indicator. Biol Trace Elem Res 1983;5:529-537
14. Kelsey KT, Hirao T, Schned A, et al. A population-based study of immunohistochemical detection of p53 alteration in bladder cancer. Br J Cancer 2004;90:1572-1576 (Pubitemid 38648240)
15. Knekt P, Aromaa A, Maatela J, et al. Serum selenium and subsequent risk of cancer among Finnish men and women. J Natl Cancer Inst 1990;82:864-868 (Pubitemid 20149447)
16. The α-Tocopherol, β-Carotene Cancer Prevention Study Group. The effect of vitamin E and β-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-1035
17. Omenn GS, Goodman GE, Thomquist MD, et al. Effects of a combination of β-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-1155 (Pubitemid 26137973)
18. Baron JA, Cole BF, Mott L, et al. Neoplastic and antineoplastic effects of β-carotene on colorectal adenoma recurrence: results of a randomized trial. J Natl Cancer Inst 2003;95:717-722 (Pubitemid 36665499)
19. Seo YR, Kelley MR, Smith ML. Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc Natl Acad Sci U S A 2002;99:14548-14553
20. El-Bayoumy K, Sinha R. Molecular chemoprevention by selenium: a genomic approach. Mutat Res 2005;591:224-236 (Pubitemid 41654851)
21. Goel A, Fuerst F, Hotchkiss E, Boland CR. Selenomethionine induces p53 mediated cell cycle arrest and apoptosis in human colon cancer cells. Cancer Biol Ther 2006;5:529-535 (Pubitemid 43765289)
22. Zhao R, Xiang N, Domann FE, Zhong W. Expression of p53 enhances selenite-induced superoxide production and apoptosis in human prostate cancer cells. Cancer Res 2006;66:2296-2304 (Pubitemid 43294943)